Neuvivo
Neuvivo is a late clinical-stage biopharmaceutical company developing a new ALS treatment.
Neuvivo is a business in biotechnology based in San Francisco Bay Area, Silicon Valley, West Coast, Western US, founded in 2020.
Neuvivo is positioned in biotechnology, a segment that rewards a clear, focused offering.
Its base of operations is San Francisco Bay Area, Silicon Valley, West Coast, Western US.
The company is listed at the Series_Unknown stage of development.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $11M in funding.
| Sector | Biotechnology |
|---|---|
| Headquarters | San Francisco Bay Area, Silicon Valley, West Coast, Western US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $11,000,000 |
Website: www.neuvivo.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account